TY - JOUR
T1 - Short report
T2 - Antigenic relationships between sylvatic and endemic dengue viruses
AU - Vasilakis, Nikos
AU - Durbin, Anna P.
AU - Travassos Da Rosa, Amelia
AU - Munoz-Jordan, Jorge L.
AU - Tesh, Robert
AU - Weaver, Scott C.
N1 - Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2008/7
Y1 - 2008/7
N2 - Sylvatic dengue viruses (DENVs) are transmitted between non-human primates and arboreal Aedes spp. mosquitoes in Southeast Asia and west Africa. Recent evidence suggests that the risk for re-emergence of sylvatic DENV into the urban endemic/epidemic cycle may be high, which could limit the potential for eradicating the human transmission cycle with vaccines now under development. We assessed the likelihood of sylvatic DENV re-emergence in the face of immunity to current endemic strains or vaccines by evaluating the neutralization capacity of sera from DENV vaccinees and convalescent patients after primary infection with DENV-2 and DENV-3 serotypes. Our data indicate robust homotypic cross-immunity between human sera and sylvatic DENV strains, but limited heterotypic neutralization. Should a licensed vaccine lead to the eradication of the urban transmission cycle in the future, reemergence of sylvatic strains into the urban cycle would be limited by homotypic immunity mediated by virus-neutralizing antibodies.
AB - Sylvatic dengue viruses (DENVs) are transmitted between non-human primates and arboreal Aedes spp. mosquitoes in Southeast Asia and west Africa. Recent evidence suggests that the risk for re-emergence of sylvatic DENV into the urban endemic/epidemic cycle may be high, which could limit the potential for eradicating the human transmission cycle with vaccines now under development. We assessed the likelihood of sylvatic DENV re-emergence in the face of immunity to current endemic strains or vaccines by evaluating the neutralization capacity of sera from DENV vaccinees and convalescent patients after primary infection with DENV-2 and DENV-3 serotypes. Our data indicate robust homotypic cross-immunity between human sera and sylvatic DENV strains, but limited heterotypic neutralization. Should a licensed vaccine lead to the eradication of the urban transmission cycle in the future, reemergence of sylvatic strains into the urban cycle would be limited by homotypic immunity mediated by virus-neutralizing antibodies.
UR - http://www.scopus.com/inward/record.url?scp=46849105286&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=46849105286&partnerID=8YFLogxK
U2 - 10.4269/ajtmh.2008.79.128
DO - 10.4269/ajtmh.2008.79.128
M3 - Article
C2 - 18606776
AN - SCOPUS:46849105286
SN - 0002-9637
VL - 79
SP - 128
EP - 132
JO - American Journal of Tropical Medicine and Hygiene
JF - American Journal of Tropical Medicine and Hygiene
IS - 1
ER -